XML 122 R103.htm IDEA: XBRL DOCUMENT
v3.7.0.1

Guarantor Financial Information , Condensed Consolidating Statement of Cash Flows (Details) - USD ($) $ in Millions | 12 Months Ended
--- | ---
Apr. 28, 2017 | Apr. 29, 2016 | Apr. 24, 2015
Operating Activities: |  |  |
Net cash provided by operating activities | $ 6,880 | $ 5,218 | $ 4,902
Investing Activities: |  |  |
Acquisitions, net of cash acquired | (1,324) | (1,213) | (14,884)
Additions to property, plant, and equipment | (1,254) | (1,046) | (571)
Purchases of investments | (4,371) | (5,406) | (7,582)
Sales and maturities of investments | 5,356 | 9,924 | 5,890
Net (increase) decrease in intercompany loans receivable | 0 | 0 | 0
Sale of subsidiaries |  | 0 |
Capital contributions paid | 0 | 0 | 0
Other investing activities, net | 22 | (14) | 89
Net cash (used in) provided by investing activities | (1,571) | 2,245 | (17,058)
Financing Activities: |  |  |
Acquisition-related contingent consideration | (69) | (22) | (85)
Change in current debt obligations, net | 906 | 7 | (1)
Repayment of short-term borrowings (maturities greater than 90 days) | (2) | (139) | (150)
Proceeds from short-term borrowings (maturities greater than 90 days) | 12 | 139 | 150
Issuance of long-term debt | 2,140 | 0 | 19,942
Payments on long-term debt | (863) | (5,132) | (1,268)
Dividends to shareholders | (2,376) | (2,139) | (1,337)
Issuance of ordinary shares | 428 | 491 | 649
Repurchase of ordinary shares | (3,544) | (2,830) | (1,920)
Net intercompany loan borrowings (repayments) | 0 | 0 | 0
Intercompany dividend paid | 0 | 0 | 0
Capital contributions received | 0 | 0 | 0
Other financing activities | 85 | 82 | (31)
Net cash (used in) provided by financing activities | (3,283) | (9,543) | 15,949
Effect of exchange rate changes on cash and cash equivalents | 65 | 113 | (353)
Net change in cash and cash equivalents | 2,091 | (1,967) | 3,440
Cash and cash equivalents at beginning of period | 2,876 | 4,843 | 1,403
Cash and cash equivalents at end of period | 4,967 | 2,876 | 4,843
Consolidating Adjustments | Medtronic Notes |  |  |
Operating Activities: |  |  |
Net cash provided by operating activities | (887) | (812) | (413)
Investing Activities: |  |  |
Acquisitions, net of cash acquired | 0 | 0 | 0
Additions to property, plant, and equipment | 0 | 0 | 0
Purchases of investments | 162 | 0 | 0
Sales and maturities of investments | (162) | 0 | 0
Net (increase) decrease in intercompany loans receivable | 13,813 | 10,492 | 16,943
Capital contributions paid | 248 | 9,870 |
Other investing activities, net | 0 | 0 | 0
Net cash (used in) provided by investing activities | 14,061 | 20,362 | 16,943
Financing Activities: |  |  |
Acquisition-related contingent consideration | 0 | 0 | 0
Change in current debt obligations, net | 0 | 0 | 0
Repayment of short-term borrowings (maturities greater than 90 days) | 0 | 0 | 0
Proceeds from short-term borrowings (maturities greater than 90 days) | 0 | 0 | 0
Issuance of long-term debt | 0 |  | 0
Payments on long-term debt | 0 | 0 | 0
Dividends to shareholders | 0 | 0 | 0
Issuance of ordinary shares | 0 | 0 | 0
Repurchase of ordinary shares | 0 | 0 | 0
Net intercompany loan borrowings (repayments) | (13,813) | (10,492) | (16,943)
Intercompany dividend paid | 887 | 812 | 413
Capital contributions received | (248) | (9,870) |
Other financing activities | 0 | 0 | 0
Net cash (used in) provided by financing activities | (13,174) | (19,550) | (16,530)
Effect of exchange rate changes on cash and cash equivalents | 0 | 0 | 0
Net change in cash and cash equivalents | 0 | 0 | 0
Cash and cash equivalents at beginning of period | 0 | 0 | 0
Cash and cash equivalents at end of period | 0 | 0 | 0
Consolidating Adjustments | CIFSA Senior Notes |  |  |
Operating Activities: |  |  |
Net cash provided by operating activities | (1,997) | (4,005) | (1,100)
Investing Activities: |  |  |
Acquisitions, net of cash acquired | 0 | 53 | 0
Additions to property, plant, and equipment | 0 | 0 | 0
Purchases of investments | 0 | 0 | 0
Sales and maturities of investments | 0 | 0 | 0
Net (increase) decrease in intercompany loans receivable | (3,320) | 11,659 | 10,656
Sale of subsidiaries |  | (53) |
Capital contributions paid | 537 | 5,679 | 937
Other investing activities, net | 0 | 0 | 0
Net cash (used in) provided by investing activities | (2,783) | 17,338 | 11,593
Financing Activities: |  |  |
Acquisition-related contingent consideration | 0 | 0 | 0
Change in current debt obligations, net | 0 | 0 | 0
Repayment of short-term borrowings (maturities greater than 90 days) | 0 | 0 | 0
Proceeds from short-term borrowings (maturities greater than 90 days) | 0 | 0 | 0
Issuance of long-term debt | 0 |  | 0
Payments on long-term debt | 0 | 0 | 0
Dividends to shareholders | 0 | 0 | 0
Issuance of ordinary shares | 0 | 0 | 0
Repurchase of ordinary shares | 0 | 0 | 0
Net intercompany loan borrowings (repayments) | 3,320 | (11,659) | (10,656)
Intercompany dividend paid | 1,997 | 4,005 | 1,100
Capital contributions received | (537) | (5,679) | (937)
Other financing activities | 0 | 0 | 0
Net cash (used in) provided by financing activities | 4,780 | (13,333) | (10,493)
Effect of exchange rate changes on cash and cash equivalents | 0 | 0 | 0
Net change in cash and cash equivalents | 0 | 0 | 0
Cash and cash equivalents at beginning of period | 0 | 0 | 0
Cash and cash equivalents at end of period | 0 | 0 | 0
Medtronic plc | Medtronic Notes |  |  |
Operating Activities: |  |  |
Net cash provided by operating activities | 842 | 297 | 26
Investing Activities: |  |  |
Acquisitions, net of cash acquired | 0 | 0 | (9,700)
Additions to property, plant, and equipment | 0 | 0 | 0
Purchases of investments | 0 | 0 | 0
Sales and maturities of investments | 0 | 0 | 0
Net (increase) decrease in intercompany loans receivable | 0 | 0 | 0
Capital contributions paid | 0 | 0 |
Other investing activities, net | 0 | 0 | 0
Net cash (used in) provided by investing activities | 0 | 0 | (9,700)
Financing Activities: |  |  |
Acquisition-related contingent consideration | 0 | 0 | 0
Change in current debt obligations, net | 0 | 0 | 0
Repayment of short-term borrowings (maturities greater than 90 days) | 0 | 0 | 0
Proceeds from short-term borrowings (maturities greater than 90 days) | 0 | 0 | 0
Issuance of long-term debt | 0 |  | 0
Payments on long-term debt | 0 | 0 | 0
Dividends to shareholders | (2,376) | (2,139) | (435)
Issuance of ordinary shares | 428 | 491 | 172
Repurchase of ordinary shares | (3,544) | (2,830) | (300)
Net intercompany loan borrowings (repayments) | 4,650 | 3,918 | 10,500
Intercompany dividend paid | 0 | 0 | 0
Capital contributions received | 0 | 0 |
Other financing activities | 0 | 0 | 0
Net cash (used in) provided by financing activities | (842) | (560) | 9,937
Effect of exchange rate changes on cash and cash equivalents | 0 | 0 | 0
Net change in cash and cash equivalents | 0 | (263) | 263
Cash and cash equivalents at beginning of period | 0 | 263 | 0
Cash and cash equivalents at end of period | 0 | 0 | 263
Medtronic plc | CIFSA Senior Notes |  |  |
Operating Activities: |  |  |
Net cash provided by operating activities | 842 | 297 | 26
Investing Activities: |  |  |
Acquisitions, net of cash acquired | 0 | 0 | (9,700)
Additions to property, plant, and equipment | 0 | 0 | 0
Purchases of investments | 0 | 0 | 0
Sales and maturities of investments | 0 | 0 | 0
Net (increase) decrease in intercompany loans receivable | 0 | 0 | 0
Sale of subsidiaries |  | 0 |
Capital contributions paid | 0 | 0 | 0
Other investing activities, net | 0 | 0 | 0
Net cash (used in) provided by investing activities | 0 | 0 | (9,700)
Financing Activities: |  |  |
Acquisition-related contingent consideration | 0 | 0 | 0
Change in current debt obligations, net | 0 | 0 | 0
Repayment of short-term borrowings (maturities greater than 90 days) | 0 | 0 | 0
Proceeds from short-term borrowings (maturities greater than 90 days) | 0 | 0 | 0
Issuance of long-term debt | 0 |  | 0
Payments on long-term debt | 0 | 0 | 0
Dividends to shareholders | (2,376) | (2,139) | (435)
Issuance of ordinary shares | 428 | 491 | 172
Repurchase of ordinary shares | (3,544) | (2,830) | (300)
Net intercompany loan borrowings (repayments) | 4,650 | 3,918 | 10,500
Intercompany dividend paid | 0 | 0 | 0
Capital contributions received | 0 | 0 | 0
Other financing activities | 0 | 0 | 0
Net cash (used in) provided by financing activities | (842) | (560) | 9,937
Effect of exchange rate changes on cash and cash equivalents | 0 | 0 | 0
Net change in cash and cash equivalents | 0 | (263) | 263
Cash and cash equivalents at beginning of period | 0 | 263 | 0
Cash and cash equivalents at end of period | 0 | 0 | 263
Subsidiary Issuer | Medtronic Notes |  |  |
Operating Activities: |  |  |
Net cash provided by operating activities | 1,902 | 402 | 1,479
Investing Activities: |  |  |
Acquisitions, net of cash acquired | (940) | (526) | (65)
Additions to property, plant, and equipment | (369) | (334) | (187)
Purchases of investments | 0 | 0 | 0
Sales and maturities of investments | 210 | 0 | 0
Net (increase) decrease in intercompany loans receivable | (3,278) | (2,368) | (16,996)
Capital contributions paid | (248) | (11) |
Other investing activities, net | 0 | 0 | 0
Net cash (used in) provided by investing activities | (4,625) | (3,239) | (17,248)
Financing Activities: |  |  |
Acquisition-related contingent consideration | 0 | 0 | 0
Change in current debt obligations, net | 0 | 0 | 0
Repayment of short-term borrowings (maturities greater than 90 days) | 0 | 0 | (150)
Proceeds from short-term borrowings (maturities greater than 90 days) | 0 | 0 | 150
Issuance of long-term debt | 150 |  | 19,942
Payments on long-term debt | (500) | (2,988) | (1,268)
Dividends to shareholders | 0 | 0 | (902)
Issuance of ordinary shares | 0 | 0 | 477
Repurchase of ordinary shares | 0 | 0 | (1,620)
Net intercompany loan borrowings (repayments) | 3,023 | (91) | (53)
Intercompany dividend paid | 0 | 0 | 0
Capital contributions received | 0 | 4,900 |
Other financing activities | 40 | 0 | 0
Net cash (used in) provided by financing activities | 2,713 | 1,821 | 16,576
Effect of exchange rate changes on cash and cash equivalents | 0 | 0 | 0
Net change in cash and cash equivalents | (10) | (1,016) | 807
Cash and cash equivalents at beginning of period | 55 | 1,071 | 264
Cash and cash equivalents at end of period | 45 | 55 | 1,071
Subsidiary Issuer | CIFSA Senior Notes |  |  |
Operating Activities: |  |  |
Net cash provided by operating activities | 1,904 | 4,208 | 1,238
Investing Activities: |  |  |
Acquisitions, net of cash acquired | 0 | 0 | 440
Additions to property, plant, and equipment | 0 | 0 | 0
Purchases of investments | 0 | 0 | 0
Sales and maturities of investments | 0 | 0 | 0
Net (increase) decrease in intercompany loans receivable | 5,275 | (8,193) | (59)
Sale of subsidiaries |  | 0 |
Capital contributions paid | (537) | (720) | (937)
Other investing activities, net | 0 | 0 | 0
Net cash (used in) provided by investing activities | 4,738 | (8,913) | (556)
Financing Activities: |  |  |
Acquisition-related contingent consideration | 0 | 0 | 0
Change in current debt obligations, net | 0 | 0 | 0
Repayment of short-term borrowings (maturities greater than 90 days) | 0 | 0 | 0
Proceeds from short-term borrowings (maturities greater than 90 days) | 0 | 0 | 0
Issuance of long-term debt | 0 |  | 0
Payments on long-term debt | 0 | (2,121) | (51)
Dividends to shareholders | 0 | 0 | 0
Issuance of ordinary shares | 0 | 0 | 0
Repurchase of ordinary shares | 0 | 0 | 0
Net intercompany loan borrowings (repayments) | (6,817) | 6,306 | 97
Intercompany dividend paid | 0 | 0 | 0
Capital contributions received | 0 | 0 | 0
Other financing activities | 0 | 0 | 0
Net cash (used in) provided by financing activities | (6,817) | 4,185 | 46
Effect of exchange rate changes on cash and cash equivalents | 0 | 0 | 0
Net change in cash and cash equivalents | (175) | (520) | 728
Cash and cash equivalents at beginning of period | 208 | 728 | 0
Cash and cash equivalents at end of period | 33 | 208 | 728
Subsidiary Guarantors | Medtronic Notes |  |  |
Operating Activities: |  |  |
Net cash provided by operating activities | 302 | 696 | 170
Investing Activities: |  |  |
Acquisitions, net of cash acquired | 0 | 0 | 0
Additions to property, plant, and equipment | 0 | 0 | 0
Purchases of investments | 0 | 0 | 0
Sales and maturities of investments | 0 | 0 | 0
Net (increase) decrease in intercompany loans receivable | (5,911) | (203) | 0
Capital contributions paid | 0 | (4,959) |
Other investing activities, net | 0 | 0 | 0
Net cash (used in) provided by investing activities | (5,911) | (5,162) | 0
Financing Activities: |  |  |
Acquisition-related contingent consideration | 0 | 0 | 0
Change in current debt obligations, net | 901 | 0 | 0
Repayment of short-term borrowings (maturities greater than 90 days) | 0 | (139) | 0
Proceeds from short-term borrowings (maturities greater than 90 days) | 0 | 139 | 0
Issuance of long-term debt | 1,850 |  | 0
Payments on long-term debt | 0 | 0 | 0
Dividends to shareholders | 0 | 0 | 0
Issuance of ordinary shares | 0 | 0 | 0
Repurchase of ordinary shares | 0 | 0 | 0
Net intercompany loan borrowings (repayments) | 2,863 | 4,296 | 0
Intercompany dividend paid | 0 | 0 | 0
Capital contributions received | 0 | 0 |
Other financing activities | 0 | 0 | 0
Net cash (used in) provided by financing activities | 5,614 | 4,296 | 0
Effect of exchange rate changes on cash and cash equivalents | 0 | 0 | 0
Net change in cash and cash equivalents | 5 | (170) | 170
Cash and cash equivalents at beginning of period | 0 | 170 | 0
Cash and cash equivalents at end of period | 5 | 0 | 170
Subsidiary Guarantors | CIFSA Senior Notes |  |  |
Operating Activities: |  |  |
Net cash provided by operating activities | 302 | 604 | 142
Investing Activities: |  |  |
Acquisitions, net of cash acquired | 0 | 0 | 0
Additions to property, plant, and equipment | 0 | 0 | (1)
Purchases of investments | 0 | 0 | 0
Sales and maturities of investments | 0 | 0 | 0
Net (increase) decrease in intercompany loans receivable | (5,911) | (164) | 29
Sale of subsidiaries |  | 53 |
Capital contributions paid | 0 | (4,959) | 0
Other investing activities, net | 0 | 0 | 0
Net cash (used in) provided by investing activities | (5,911) | (5,070) | 28
Financing Activities: |  |  |
Acquisition-related contingent consideration | 0 | 0 | 0
Change in current debt obligations, net | 901 | 0 | 0
Repayment of short-term borrowings (maturities greater than 90 days) | 0 | (139) | (150)
Proceeds from short-term borrowings (maturities greater than 90 days) | 0 | 139 | 150
Issuance of long-term debt | 1,850 |  | 0
Payments on long-term debt | 0 | 0 | 0
Dividends to shareholders | 0 | 0 | 0
Issuance of ordinary shares | 0 | 0 | 0
Repurchase of ordinary shares | 0 | 0 | 0
Net intercompany loan borrowings (repayments) | 2,863 | 4,296 | 0
Intercompany dividend paid | 0 | 0 | 0
Capital contributions received | 0 | 0 | 0
Other financing activities | 0 | 0 | 0
Net cash (used in) provided by financing activities | 5,614 | 4,296 | 0
Effect of exchange rate changes on cash and cash equivalents | 0 | 0 | 0
Net change in cash and cash equivalents | 5 | (170) | 170
Cash and cash equivalents at beginning of period | 0 | 170 | 0
Cash and cash equivalents at end of period | 5 | 0 | 170
Subsidiary Non-guarantors | Medtronic Notes |  |  |
Operating Activities: |  |  |
Net cash provided by operating activities | 4,721 | 4,635 | 3,640
Investing Activities: |  |  |
Acquisitions, net of cash acquired | (384) | (687) | (5,119)
Additions to property, plant, and equipment | (885) | (712) | (384)
Purchases of investments | (4,533) | (5,406) | (7,582)
Sales and maturities of investments | 5,308 | 9,924 | 5,890
Net (increase) decrease in intercompany loans receivable | (4,624) | (7,921) | 53
Capital contributions paid | 0 | (4,900) |
Other investing activities, net | 22 | (14) | 89
Net cash (used in) provided by investing activities | (5,096) | (9,716) | (7,053)
Financing Activities: |  |  |
Acquisition-related contingent consideration | (69) | (22) | (85)
Change in current debt obligations, net | 5 | 7 | (1)
Repayment of short-term borrowings (maturities greater than 90 days) | (2) | 0 | 0
Proceeds from short-term borrowings (maturities greater than 90 days) | 12 | 0 | 0
Issuance of long-term debt | 140 |  | 0
Payments on long-term debt | (363) | (2,144) | 0
Dividends to shareholders | 0 | 0 | 0
Issuance of ordinary shares | 0 | 0 | 0
Repurchase of ordinary shares | 0 | 0 | 0
Net intercompany loan borrowings (repayments) | 3,277 | 2,369 | 6,496
Intercompany dividend paid | (887) | (812) | (413)
Capital contributions received | 248 | 4,970 |
Other financing activities | 45 | 82 | (31)
Net cash (used in) provided by financing activities | 2,406 | 4,450 | 5,966
Effect of exchange rate changes on cash and cash equivalents | 65 | 113 | (353)
Net change in cash and cash equivalents | 2,096 | (518) | 2,200
Cash and cash equivalents at beginning of period | 2,821 | 3,339 | 1,139
Cash and cash equivalents at end of period | 4,917 | 2,821 | 3,339
Subsidiary Non-guarantors | CIFSA Senior Notes |  |  |
Operating Activities: |  |  |
Net cash provided by operating activities | 5,829 | 4,114 | 4,596
Investing Activities: |  |  |
Acquisitions, net of cash acquired | (1,324) | (1,266) | (5,624)
Additions to property, plant, and equipment | (1,254) | (1,046) | (570)
Purchases of investments | (4,371) | (5,406) | (7,582)
Sales and maturities of investments | 5,356 | 9,924 | 5,890
Net (increase) decrease in intercompany loans receivable | 3,956 | (3,302) | (10,626)
Sale of subsidiaries |  | 0 |
Capital contributions paid | 0 | 0 | 0
Other investing activities, net | 22 | (14) | 89
Net cash (used in) provided by investing activities | 2,385 | (1,110) | (18,423)
Financing Activities: |  |  |
Acquisition-related contingent consideration | (69) | (22) | (85)
Change in current debt obligations, net | 5 | 7 | (1)
Repayment of short-term borrowings (maturities greater than 90 days) | (2) | 0 | 0
Proceeds from short-term borrowings (maturities greater than 90 days) | 12 | 0 | 0
Issuance of long-term debt | 290 |  | 19,942
Payments on long-term debt | (863) | (3,011) | (1,217)
Dividends to shareholders | 0 | 0 | (902)
Issuance of ordinary shares | 0 | 0 | 477
Repurchase of ordinary shares | 0 | 0 | (1,620)
Net intercompany loan borrowings (repayments) | (4,016) | (2,861) | 59
Intercompany dividend paid | (1,997) | (4,005) | (1,100)
Capital contributions received | 537 | 5,679 | 937
Other financing activities | 85 | 82 | (31)
Net cash (used in) provided by financing activities | (6,018) | (4,131) | 16,459
Effect of exchange rate changes on cash and cash equivalents | 65 | 113 | (353)
Net change in cash and cash equivalents | 2,261 | (1,014) | 2,279
Cash and cash equivalents at beginning of period | 2,668 | 3,682 | 1,403
Cash and cash equivalents at end of period | $ 4,929 | $ 2,668 | $ 3,682

X
- Definition Amount of cash payments made under the contingent consideration arrangement in business acquisition. + References No definition available. + Details
Name: | mdt_BusinessAcquisitionContingentConsiderationCashPayment
Namespace Prefix: | mdt_
Data Type: | xbrli:monetaryItemType
Balance Type: | credit
Period Type: | duration

X
- Definition Increase (Decrease) In Intercompany Receivable + References No definition available. + Details
Name: | mdt_IncreaseDecreaseInIntercompanyReceivable
Namespace Prefix: | mdt_
Data Type: | xbrli:monetaryItemType
Balance Type: | credit
Period Type: | duration

X
- Definition Increase (Decrease) in Intercompany Payable + References No definition available. + Details
Name: | mdt_IncreaseDecreaseinIntercompanyPayable
Namespace Prefix: | mdt_
Data Type: | xbrli:monetaryItemType
Balance Type: | debit
Period Type: | duration

X
- Definition Increase in Investment in Subsidiary + References No definition available. + Details
Name: | mdt_IncreaseinInvestmentinSubsidiary
Namespace Prefix: | mdt_
Data Type: | xbrli:monetaryItemType
Balance Type: | credit
Period Type: | duration

X
- Definition Intercompany Dividends Paid + References No definition available. + Details
Name: | mdt_IntercompanyDividendsPaid
Namespace Prefix: | mdt_
Data Type: | xbrli:monetaryItemType
Balance Type: | credit
Period Type: | duration

X
- Definition Amount of currency on hand as well as demand deposits with banks or financial institutions. Includes other kinds of accounts that have the general characteristics of demand deposits. Also includes short-term, highly liquid investments that are both readily convertible to known amounts of cash and so near their maturity that they present insignificant risk of changes in value because of changes in interest rates. Excludes cash and cash equivalents within disposal group and discontinued operation. + References Reference 1: http://www.xbrl.org/2003/role/presentationRef -Publisher FASB -Name Accounting Standards Codification -Topic 210 -SubTopic 10 -Section 45 -Paragraph 1 -Subparagraph (a) -URI http://asc.fasb.org/extlink&oid=82887183&loc=d3e6676-107765 Reference 2: http://www.xbrl.org/2003/role/presentationRef -Publisher FASB -Name Accounting Standards Codification -Topic 230 -SubTopic 10 -Section 45 -Paragraph 4 -URI http://asc.fasb.org/extlink&oid=98514028&loc=d3e3044-108585 Reference 3: http://www.xbrl.org/2003/role/presentationRef -Publisher FASB -Name Accounting Standards Codification -Topic 210 -SubTopic 10 -Section S99 -Paragraph 1 -Subparagraph (SX 210.5-02.1) -URI http://asc.fasb.org/extlink&oid=6877327&loc=d3e13212-122682 + Details
Name: | us-gaap_CashAndCashEquivalentsAtCarryingValue
Namespace Prefix: | us-gaap_
Data Type: | xbrli:monetaryItemType
Balance Type: | debit
Period Type: | instant

X
- Definition Amount of increase (decrease) in cash and cash equivalents. Cash and cash equivalents are the amount of currency on hand as well as demand deposits with banks or financial institutions. Includes other kinds of accounts that have the general characteristics of demand deposits. Also includes short-term, highly liquid investments that are both readily convertible to known amounts of cash and so near their maturity that they present insignificant risk of changes in value because of changes in interest rates. Includes effect from exchange rate changes. + References Reference 1: http://www.xbrl.org/2003/role/presentationRef -Publisher FASB -Name Accounting Standards Codification -Topic 230 -SubTopic 10 -Section 45 -Paragraph 24 -URI http://asc.fasb.org/extlink&oid=98514028&loc=d3e3521-108585 Reference 2: http://www.xbrl.org/2003/role/presentationRef -Publisher FASB -Name Accounting Standards Codification -Topic 830 -SubTopic 230 -Section 45 -Paragraph 1 -URI http://asc.fasb.org/extlink&oid=98513438&loc=d3e33268-110906 + Details
Name: | us-gaap_CashAndCashEquivalentsPeriodIncreaseDecrease
Namespace Prefix: | us-gaap_
Data Type: | xbrli:monetaryItemType
Balance Type: | debit
Period Type: | duration

X
- Definition Amount of increase (decrease) from the effect of exchange rate changes on cash and cash equivalent balances held in foreign currencies. + References Reference 1: http://www.xbrl.org/2003/role/presentationRef -Publisher FASB -Name Accounting Standards Codification -Topic 830 -SubTopic 230 -Section 45 -Paragraph 1 -URI http://asc.fasb.org/extlink&oid=98513438&loc=d3e33268-110906 + Details
Name: | us-gaap_EffectOfExchangeRateOnCashAndCashEquivalents
Namespace Prefix: | us-gaap_
Data Type: | xbrli:monetaryItemType
Balance Type: | debit
Period Type: | duration

X
- Definition Amount of cash inflow (outflow) from financing activities, including discontinued operations. Financing activity cash flows include obtaining resources from owners and providing them with a return on, and a return of, their investment; borrowing money and repaying amounts borrowed, or settling the obligation; and obtaining and paying for other resources obtained from creditors on long-term credit. + References Reference 1: http://www.xbrl.org/2003/role/presentationRef -Publisher FASB -Name Accounting Standards Codification -Topic 230 -SubTopic 10 -Section 45 -Paragraph 24 -URI http://asc.fasb.org/extlink&oid=98514028&loc=d3e3521-108585 Reference 2: http://www.xbrl.org/2003/role/presentationRef -Publisher FASB -Name Accounting Standards Codification -Topic 230 -SubTopic 10 -Section 45 -Paragraph 26 -URI http://asc.fasb.org/extlink&oid=98514028&loc=d3e3574-108585 + Details
Name: | us-gaap_NetCashProvidedByUsedInFinancingActivities
Namespace Prefix: | us-gaap_
Data Type: | xbrli:monetaryItemType
Balance Type: | debit
Period Type: | duration

X
- References No definition available. + Details
Name: | us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract
Namespace Prefix: | us-gaap_
Data Type: | xbrli:stringItemType
Balance Type: | na
Period Type: | duration

X
- Definition Amount of cash inflow (outflow) from investing activities, including discontinued operations. Investing activity cash flows include making and collecting loans and acquiring and disposing of debt or equity instruments and property, plant, and equipment and other productive assets. + References Reference 1: http://www.xbrl.org/2003/role/presentationRef -Publisher FASB -Name Accounting Standards Codification -Topic 230 -SubTopic 10 -Section 45 -Paragraph 24 -URI http://asc.fasb.org/extlink&oid=98514028&loc=d3e3521-108585 Reference 2: http://www.xbrl.org/2003/role/presentationRef -Publisher FASB -Name Accounting Standards Codification -Topic 230 -SubTopic 10 -Section 45 -Paragraph 26 -URI http://asc.fasb.org/extlink&oid=98514028&loc=d3e3574-108585 + Details
Name: | us-gaap_NetCashProvidedByUsedInInvestingActivities
Namespace Prefix: | us-gaap_
Data Type: | xbrli:monetaryItemType
Balance Type: | debit
Period Type: | duration

X
- References No definition available. + Details
Name: | us-gaap_NetCashProvidedByUsedInInvestingActivitiesAbstract
Namespace Prefix: | us-gaap_
Data Type: | xbrli:stringItemType
Balance Type: | na
Period Type: | duration

X
- Definition Amount of cash inflow (outflow) from operating activities, including discontinued operations. Operating activity cash flows include transactions, adjustments, and changes in value not defined as investing or financing activities. + References Reference 1: http://www.xbrl.org/2003/role/presentationRef -Publisher FASB -Name Accounting Standards Codification -Topic 230 -SubTopic 10 -Section 45 -Paragraph 24 -URI http://asc.fasb.org/extlink&oid=98514028&loc=d3e3521-108585 Reference 2: http://www.xbrl.org/2003/role/presentationRef -Publisher FASB -Name Accounting Standards Codification -Topic 230 -SubTopic 10 -Section 45 -Paragraph 28 -URI http://asc.fasb.org/extlink&oid=98514028&loc=d3e3602-108585 Reference 3: http://www.xbrl.org/2003/role/presentationRef -Publisher FASB -Name Accounting Standards Codification -Topic 230 -SubTopic 10 -Section 45 -Paragraph 25 -URI http://asc.fasb.org/extlink&oid=98514028&loc=d3e3536-108585 + Details
Name: | us-gaap_NetCashProvidedByUsedInOperatingActivities
Namespace Prefix: | us-gaap_
Data Type: | xbrli:monetaryItemType
Balance Type: | na
Period Type: | duration

X
- References No definition available. + Details
Name: | us-gaap_NetCashProvidedByUsedInOperatingActivitiesAbstract
Namespace Prefix: | us-gaap_
Data Type: | xbrli:stringItemType
Balance Type: | na
Period Type: | duration

X
- Definition Amount of cash (inflow) outflow from investing activities classified as other. + References Reference 1: http://www.xbrl.org/2003/role/presentationRef -Publisher FASB -Name Accounting Standards Codification -Topic 230 -SubTopic 10 -Section 45 -Paragraph 9 -URI http://asc.fasb.org/extlink&oid=98514028&loc=d3e3098-108585 Reference 2: http://www.xbrl.org/2003/role/presentationRef -Publisher FASB -Name Accounting Standards Codification -Topic 230 -SubTopic 10 -Section 45 -Paragraph 8 -URI http://asc.fasb.org/extlink&oid=98514028&loc=d3e3095-108585 + Details
Name: | us-gaap_PaymentsForProceedsFromOtherInvestingActivities
Namespace Prefix: | us-gaap_
Data Type: | xbrli:monetaryItemType
Balance Type: | credit
Period Type: | duration

X
- Definition The cash outflow to reacquire common stock during the period. + References Reference 1: http://www.xbrl.org/2003/role/presentationRef -Publisher FASB -Name Accounting Standards Codification -Topic 230 -SubTopic 10 -Section 45 -Paragraph 15 -Subparagraph (a) -URI http://asc.fasb.org/extlink&oid=98514028&loc=d3e3291-108585 + Details
Name: | us-gaap_PaymentsForRepurchaseOfCommonStock
Namespace Prefix: | us-gaap_
Data Type: | xbrli:monetaryItemType
Balance Type: | credit
Period Type: | duration

X
- Definition Amount of cash outflow in the form of ordinary dividends to common shareholders of the parent entity. + References Reference 1: http://www.xbrl.org/2003/role/presentationRef -Publisher FASB -Name Accounting Standards Codification -Topic 230 -SubTopic 10 -Section 45 -Paragraph 15 -Subparagraph (a) -URI http://asc.fasb.org/extlink&oid=98514028&loc=d3e3291-108585 + Details
Name: | us-gaap_PaymentsOfDividendsCommonStock
Namespace Prefix: | us-gaap_
Data Type: | xbrli:monetaryItemType
Balance Type: | credit
Period Type: | duration

X
- Definition The cash outflow associated with the acquisition of a business, net of the cash acquired from the purchase. + References Reference 1: http://www.xbrl.org/2003/role/presentationRef -Publisher FASB -Name Accounting Standards Codification -Topic 230 -SubTopic 10 -Section 45 -Paragraph 13 -Subparagraph (b) -URI http://asc.fasb.org/extlink&oid=98514028&loc=d3e3213-108585 + Details
Name: | us-gaap_PaymentsToAcquireBusinessesNetOfCashAcquired
Namespace Prefix: | us-gaap_
Data Type: | xbrli:monetaryItemType
Balance Type: | credit
Period Type: | duration

X
- Definition The cash outflow associated with the acquisition of or advances to an entity that is related to it but not strictly controlled (for example, an unconsolidated subsidiary, affiliate, and joint venture or equity method investment) or the acquisition of an additional interest in a subsidiary (controlled entity). + References Reference 1: http://www.xbrl.org/2003/role/presentationRef -Publisher FASB -Name Accounting Standards Codification -Topic 230 -SubTopic 10 -Section 45 -Paragraph 13 -Subparagraph (b) -URI http://asc.fasb.org/extlink&oid=98514028&loc=d3e3213-108585 + Details
Name: | us-gaap_PaymentsToAcquireInterestInSubsidiariesAndAffiliates
Namespace Prefix: | us-gaap_
Data Type: | xbrli:monetaryItemType
Balance Type: | credit
Period Type: | duration

X
- Definition The cash outflow associated with the purchase of all investments (debt, security, other) during the period. + References Reference 1: http://www.xbrl.org/2003/role/presentationRef -Publisher FASB -Name Accounting Standards Codification -Topic 230 -SubTopic 10 -Section 45 -Paragraph 13 -URI http://asc.fasb.org/extlink&oid=98514028&loc=d3e3213-108585 + Details
Name: | us-gaap_PaymentsToAcquireInvestments
Namespace Prefix: | us-gaap_
Data Type: | xbrli:monetaryItemType
Balance Type: | credit
Period Type: | duration

X
- Definition The cash outflow associated with the acquisition of long-lived, physical assets that are used in the normal conduct of business to produce goods and services and not intended for resale; includes cash outflows to pay for construction of self-constructed assets. + References Reference 1: http://www.xbrl.org/2003/role/presentationRef -Publisher FASB -Name Accounting Standards Codification -Topic 230 -SubTopic 10 -Section 45 -Paragraph 13 -Subparagraph (c) -URI http://asc.fasb.org/extlink&oid=98514028&loc=d3e3213-108585 + Details
Name: | us-gaap_PaymentsToAcquirePropertyPlantAndEquipment
Namespace Prefix: | us-gaap_
Data Type: | xbrli:monetaryItemType
Balance Type: | credit
Period Type: | duration

X
- Definition The cash inflow from an entity that is affiliated with the entity by means of direct or indirect ownership. + References Reference 1: http://www.xbrl.org/2003/role/presentationRef -Publisher FASB -Name Accounting Standards Codification -Topic 230 -SubTopic 10 -Section 45 -Paragraph 14 -URI http://asc.fasb.org/extlink&oid=98514028&loc=d3e3255-108585 + Details
Name: | us-gaap_ProceedsFromContributionsFromAffiliates
Namespace Prefix: | us-gaap_
Data Type: | xbrli:monetaryItemType
Balance Type: | debit
Period Type: | duration

X
- Definition The cash inflow from a debt initially having maturity due after one year or beyond the operating cycle, if longer. + References Reference 1: http://www.xbrl.org/2003/role/presentationRef -Publisher FASB -Name Accounting Standards Codification -Topic 230 -SubTopic 10 -Section 45 -Paragraph 14 -Subparagraph (b) -URI http://asc.fasb.org/extlink&oid=98514028&loc=d3e3255-108585 + Details
Name: | us-gaap_ProceedsFromIssuanceOfLongTermDebt
Namespace Prefix: | us-gaap_
Data Type: | xbrli:monetaryItemType
Balance Type: | debit
Period Type: | duration

X
- Definition The cash inflow from the issuance of common stock, preferred stock, treasury stock, stock options, and other types of equity. + References Reference 1: http://www.xbrl.org/2003/role/presentationRef -Publisher FASB -Name Accounting Standards Codification -Topic 230 -SubTopic 10 -Section 45 -Paragraph 14 -Subparagraph (a) -URI http://asc.fasb.org/extlink&oid=98514028&loc=d3e3255-108585 + Details
Name: | us-gaap_ProceedsFromIssuanceOrSaleOfEquity
Namespace Prefix: | us-gaap_
Data Type: | xbrli:monetaryItemType
Balance Type: | debit
Period Type: | duration

X
- Definition Amount of cash inflow (outflow) from financing activities classified as other. + References Reference 1: http://www.xbrl.org/2003/role/presentationRef -Publisher FASB -Name Accounting Standards Codification -Topic 230 -SubTopic 10 -Section 45 -Paragraph 8 -URI http://asc.fasb.org/extlink&oid=98514028&loc=d3e3095-108585 Reference 2: http://www.xbrl.org/2003/role/presentationRef -Publisher FASB -Name Accounting Standards Codification -Topic 230 -SubTopic 10 -Section 45 -Paragraph 9 -URI http://asc.fasb.org/extlink&oid=98514028&loc=d3e3098-108585 + Details
Name: | us-gaap_ProceedsFromPaymentsForOtherFinancingActivities
Namespace Prefix: | us-gaap_
Data Type: | xbrli:monetaryItemType
Balance Type: | debit
Period Type: | duration

X
- Definition The net cash inflow or outflow for borrowing having initial term of repayment within one year or the normal operating cycle, if longer. + References Reference 1: http://www.xbrl.org/2003/role/presentationRef -Publisher FASB -Name Accounting Standards Codification -Topic 230 -SubTopic 10 -Section 45 -Paragraph 9 -Subparagraph (c) -URI http://asc.fasb.org/extlink&oid=98514028&loc=d3e3098-108585 + Details
Name: | us-gaap_ProceedsFromRepaymentsOfShortTermDebt
Namespace Prefix: | us-gaap_
Data Type: | xbrli:monetaryItemType
Balance Type: | debit
Period Type: | duration

X
- Definition The cash inflow associated with the sale, maturity and collection of all investments such as debt, security and so forth during the period. + References Reference 1: http://www.xbrl.org/2003/role/presentationRef -Publisher FASB -Name Accounting Standards Codification -Topic 230 -SubTopic 10 -Section 45 -Paragraph 12 -URI http://asc.fasb.org/extlink&oid=98514028&loc=d3e3179-108585 + Details
Name: | us-gaap_ProceedsFromSaleMaturityAndCollectionsOfInvestments
Namespace Prefix: | us-gaap_
Data Type: | xbrli:monetaryItemType
Balance Type: | debit
Period Type: | duration

X
- Definition The cash inflow from a borrowing having initial term of repayment of more than three months but less than one year or one operating cycle (if the normal cycle is more than one year). + References Reference 1: http://www.xbrl.org/2003/role/presentationRef -Publisher FASB -Name Accounting Standards Codification -Topic 230 -SubTopic 10 -Section 45 -Paragraph 14 -Subparagraph (b) -URI http://asc.fasb.org/extlink&oid=98514028&loc=d3e3255-108585 + Details
Name: | us-gaap_ProceedsFromShortTermDebtMaturingInMoreThanThreeMonths
Namespace Prefix: | us-gaap_
Data Type: | xbrli:monetaryItemType
Balance Type: | debit
Period Type: | duration

X
- Definition The cash outflow for debt initially having maturity due after one year or beyond the normal operating cycle, if longer. + References Reference 1: http://www.xbrl.org/2003/role/presentationRef -Publisher FASB -Name Accounting Standards Codification -Topic 230 -SubTopic 10 -Section 45 -Paragraph 15 -Subparagraph (b) -URI http://asc.fasb.org/extlink&oid=98514028&loc=d3e3291-108585 + Details
Name: | us-gaap_RepaymentsOfLongTermDebt
Namespace Prefix: | us-gaap_
Data Type: | xbrli:monetaryItemType
Balance Type: | credit
Period Type: | duration

X
- Definition The cash outflow from a repayment of a borrowing having initial term of repayment of more than three months but less than one year or one operating cycle (if the normal cycle is more than one year). + References Reference 1: http://www.xbrl.org/2003/role/presentationRef -Publisher FASB -Name Accounting Standards Codification -Topic 230 -SubTopic 10 -Section 45 -Paragraph 15 -Subparagraph (b) -URI http://asc.fasb.org/extlink&oid=98514028&loc=d3e3291-108585 + Details
Name: | us-gaap_RepaymentsOfShortTermDebtMaturingInMoreThanThreeMonths
Namespace Prefix: | us-gaap_
Data Type: | xbrli:monetaryItemType
Balance Type: | credit
Period Type: | duration

X
- Details
Name: | us-gaap_ConsolidationItemsAxis=us-gaap_ConsolidationEliminationsMember
Namespace Prefix: |
Data Type: | na
Balance Type: |
Period Type: |

X
- Details
Name: | us-gaap_DebtInstrumentAxis=mdt_GuarantorsMedtronicNotesMember
Namespace Prefix: |
Data Type: | na
Balance Type: |
Period Type: |

X
- Details
Name: | us-gaap_DebtInstrumentAxis=mdt_CIFSANotesMember
Namespace Prefix: |
Data Type: | na
Balance Type: |
Period Type: |

X
- Details
Name: | us-gaap_ConsolidatedEntitiesAxis=us-gaap_ParentCompanyMember
Namespace Prefix: |
Data Type: | na
Balance Type: |
Period Type: |

X
- Details
Name: | us-gaap_ConsolidatedEntitiesAxis=us-gaap_SubsidiaryIssuerMember
Namespace Prefix: |
Data Type: | na
Balance Type: |
Period Type: |

X
- Details
Name: | us-gaap_ConsolidatedEntitiesAxis=us-gaap_GuarantorSubsidiariesMember
Namespace Prefix: |
Data Type: | na
Balance Type: |
Period Type: |

X
- Details
Name: | us-gaap_ConsolidatedEntitiesAxis=us-gaap_NonGuarantorSubsidiariesMember
Namespace Prefix: |
Data Type: | na
Balance Type: |
Period Type: |